Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical research trials and Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion). Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) clinical trial. Test subjects typically obtain the finest healthcare available for their Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "T" Clinical Trials Conditions > Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)



Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

For Condition: Alcoholism,Attention Deficit Hyperactivity Disorder
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This study will compare the effectiveness of sustained release bupropion (Wellbutrin) versus a placebo in the treatment of adolescents with comorbid alcohol use disorder and attention deficit hyperactivity disorder. Adolescents, ages 14-18 will be recruited from community treatment programs for a 16-week trial with follow-up assessments.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Double-Blind, Placebo Control, Parallel Assignment
Minimum Age/Maximum Age: 14 Years/18 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Meets criteria for alcohol use disorder and attention deficit hyperactivity disorder. - Adolescents, ages 14-18. Exclusion Criteria: - Adolescents who are pregnant. - Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk. - History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders. - Currently on other psychotropic medications from which discontinuation would present a significant risk. - A current episode of major depressive disorder or a diagnosis of bipolar disorder. - Diagnosis of dependence for any substance other than marijuana. - Adolescents with a full-scale IQ below 80.
Total Enrollment: 80

Location and Contact Information:

Western Psychiatric Institute and Clinic *Recruiting*
Pittsburgh,  Pennsylvania,  15213
United States
Recruiting Dr.  Bukstein 412-624-9167


Additional Information:
Study ID Numbers:
  NIAAABUK00301; 
Study Start Date: September 2001
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029614

Other Alcoholism Studies:
1. Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

2. Treatment of Youth with ADHD and Anxiety

3. Behavior in Children with Attention Deficit Hyperactivity Disorder and in Healthy Volunteers

Related Studies:

Other Alcoholism Clinical Trials
Other Pennsylvania Clinical Trials
Other Pittsburgh Clinical Trials

Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

Modify your Search

  Other Alcoholism Clinical Trials
  Other Pennsylvania Clinical Trials
  Other Pittsburgh Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103